After reading this you will know which species the reishi name covers, why fruiting body, mycelium and spores need separate specifications, and how triterpene and beta-glucan figures should be measured.
Reishi is a cultivated polypore, and the name on the label covers more than one species
Reishi, or lingzhi, is a woody, varnished bracket fungus of the genus Ganoderma. Trade documents almost always call it Ganoderma lucidum. In 2012 a study in Fungal Diversity showed that the lingzhi commercially cultivated in East Asia is a different species from the true G. lucidum described from Europe, and named it G. lingzhi. The naming has been debated since, and the Chinese Pharmacopoeia and China’s food and medicine list still name G. lucidum alongside G. sinense.
For a buyer, the practical point is identity. Once reishi is milled, morphology is no help, and a 2025 survey of commercial Ganoderma in China found roughly one sample in five adulterated or misidentified, with G. resinaceum among the substitutes. Your specification should state the name used, the authority behind it and the identity method, usually DNA barcoding.
A fungus is not a plant. Reishi sits in this library because it is traded, specified and regulated alongside botanical raw materials.
Fruiting body, mycelium and spores are three different materials
The fruiting body is the varnished cap and stalk, and it is what the long-standing trade and most regulatory entries describe. Mycelium is the vegetative network, often grown on cooked grain. When the mycelium is dried and milled together with that grain, the powder carries the grain’s starch. Spores are collected separately from mature fruiting bodies, are often sold with the spore wall broken, and are the raw material for spore oil.
The three differ in composition, cost and regulatory status, and a label reading reishi does not say which is inside. Treat each as its own ingredient with its own specification.
Log-grown and bag-grown fruiting bodies are both cultivated, and the specification should say which
Reishi fruiting bodies in commerce are cultivated rather than wild-collected. Two systems dominate. Log cultivation inoculates short sections of hardwood and fruits them outdoors or under cover. Substrate-bag cultivation uses supplemented sawdust in bags or bottles under controlled conditions.
Both produce genuine fruiting bodies. What changes is the substrate, the growing environment and the degree of control, and those feed into contaminant profile and batch consistency. Ask which system produced the lot, what the substrate was, and whether it will stay the same from delivery to delivery.
Triterpenes and polysaccharides are the markers, and the method decides the number
Two groups of constituents characterise reishi. Lanostane triterpenoids, the ganoderic acids among them, account for its marked bitterness. Polysaccharides, including beta-glucans, form the larger carbohydrate fraction. Hot-water extraction concentrates the polysaccharides, ethanol extraction concentrates the triterpenoids, and a dual extract combines the two.
The Chinese Pharmacopoeia monograph for Lingzhi sets minimum contents for total polysaccharides and total triterpenes, determined by colorimetric methods. Colorimetric totals are class assays: useful for grading, but they respond to anything with the right chemistry, and a polysaccharide colorimetric figure counts starch and carriers as readily as fungal glucan. HPLC profiling of individual triterpenic acids is more informative for identity, and published work has used triterpenic acid profiles alongside DNA to separate G. lucidum from G. lingzhi.
For glucans, ask for beta-glucan by the enzymatic approach published by McCleary and Draga in the Journal of AOAC International in 2016 and sold as the Megazyme K-YBGL kit, and ask for the alpha-glucan result reported alongside it. Alpha-glucan is essentially starch, so a high figure in a product sold as fruiting body is a question worth asking. The same paper reported that Ganoderma gave significantly higher total glucan values under its sulfuric acid hydrolysis than under alternatives, which is one reason two laboratories can disagree.
Contaminants follow the substrate as well as the species
A reishi specification should cover heavy metals (lead, cadmium, mercury and arsenic), pesticide residues, microbiology and moisture, and, for extracts, residual solvent. Substrate is a route for all of them, whether hardwood, supplemented sawdust or grain.
Limits depend on the market. When China added Lingzhi to its list of substances that are both food and traditional Chinese medicine, it set limits for the fruiting body of 1.0 mg/kg lead, 0.5 mg/kg cadmium, 1.0 mg/kg arsenic and 0.1 mg/kg mercury. In the European Union, Commission Regulation (EU) 2023/915 sets maximum levels for contaminants in food, including food supplements as placed on the market.
Reishi’s regulatory position is clearer than most, but only for the fruiting body
The EU Novel Food Catalogue treats the Ganoderma lucidum fruiting body and its aqueous extract powder as not novel in food, including food supplements, and treats dehydrated mycelium powder as an unauthorised novel food. The 2019 Spanish consultation behind the mycelium entry accepted a history of consumption for the fruiting body before 15 May 1997 but declined to extend it to the mycelium. A 2026 Czech consultation concluded that an aqueous extract powder from the fruiting body is not novel. Confirm the position of spore powder, spore oil and hydroalcoholic extracts before an EU launch.
In November 2023 China’s National Health Commission added G. lucidum and G. sinense fruiting body to its list of substances traditionally regarded as both food and Chinese medicine, with advice that infants and pregnant and lactating women should not consume them.
In the United States reishi is sold as a dietary ingredient under the Dietary Supplement Health and Education Act of 1994, subject to the new dietary ingredient rules for material not marketed before 15 October 1994. Labelling of mycelium against fruiting body has been the subject of citizen petitions to the FDA since 2023. In South Africa classification turns on presentation and claim, with products presented as medicines falling under the Medicines and Related Substances Act 101 of 1965 and SAHPRA.
Questions brand owners ask
Should my label say G. lucidum or G. lingzhi?
Follow the name your target market’s reference documents use, which for the EU catalogue and the Chinese Pharmacopoeia is G. lucidum, and keep the identity evidence on file. If your supplier’s DNA result says G. lingzhi, your regulatory advisers should decide how to reconcile the two before artwork.
Mycelium powder is cheaper. Can I use it?
In the EU, dehydrated mycelium powder is an unauthorised novel food. Elsewhere it may be permitted, but it is a different material, and a label that says reishi should say which part is in the pack.
Can spore powder go into the same product?
It can be formulated together, but it needs its own specification and its own regulatory check. The catalogue entries address the fruiting body, its aqueous extract and the mycelium.
Which figures should the certificate carry?
Species and identity method, part used, total triterpenes and polysaccharides with methods named, beta-glucan and alpha-glucan by the enzymatic method, heavy metals, pesticide residues and microbiology.
Can I use traditional use in positioning?
Traditional use is an ethnobotanical fact. It does not demonstrate efficacy and establishes no effect for any product.
How Afriplex supplies reishi
We supply Reishi Powder in our Botanical Powders range, reishi sourced to specification, with the part stated on the specification, and released against a certificate of analysis. Specifications are available on request. Our SAHPRA-licensed laboratory carries out method development, validation, release and stability testing, and we manufacture finished formats including capsules, tablets, powders and sachets under a SAHPRA section 22C(1)(b) licence in Paarl.
Product classification and claim substantiation remain the responsibility of the party placing the finished product on the market, and our regulatory affairs team supports customers through that process.
This article describes a botanical ingredient supplied to businesses for formulation. It is not directed at consumers, it does not describe a finished product, and nothing in it is a therapeutic claim or medical advice. Regulatory classification varies by country.



